Kirchgraber Paul R 4
4 · LABORATORY CORP OF AMERICA HOLDINGS · Filed Feb 9, 2023
Insider Transaction Report
Form 4
Kirchgraber Paul R
CEO, Covance Drug Development
Transactions
- Award
Non-qualified Stock Options
2023-02-07+5,000→ 5,000 totalExercise: $247.24From: 2024-02-07Exp: 2033-02-06→ Common Stock (5,000 underlying) - Award
Restricted Stock Unit
2023-02-07+1,590→ 3,484 total→ Common Stock (1,590 underlying)
Footnotes (5)
- [F1]Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
- [F2]The Restricted Stock Units vest in three equal annual installments beginning on February 7, 2024.
- [F3]This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
- [F4]Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- [F5]The option vests in three equal annual installments beginning on the date reflected in this column.